PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ciclosporin 0.05% Eye Drops - Dry eyes

PAD Profile : Ciclosporin 0.05% Eye Drops - Dry eyes

Brand Names Include :
Restasis, Optimmune 0.2%

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Eye drops
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
06 July 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Restatis (ciclosporin 0.05% eye drops) is considered to be a RED drug and initiation and continuation of supply should be from a specialist clinician. The local guidance below was updated in December 2016 in relation to ciclosporin preparations following the publication of NICE guidance for Ikervis (ciclosporin 1% eye drops)

Associated BNF Codes

11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More